Heterotypic cell-in-cell structures between cancer and NK cells are associated with enhanced anticancer drug resistance

被引:10
作者
Choe, Yun-Jeong [1 ]
Min, Jin Young [1 ,2 ]
Lee, Hyunseong [1 ]
Lee, Sang-Yeop [1 ]
Kwon, Joseph [3 ]
Kim, Hye-Jin [4 ]
Lee, Jangho [5 ]
Kim, Hyun Min [1 ]
Park, Hye Sun [1 ]
Cho, Mi Young [1 ]
Hyun, Ju-Yong [1 ]
Kim, Hye Min [1 ,6 ]
Chung, Yong-Ho [1 ,8 ]
Ha, Sang Keun [5 ,6 ]
Jeong, Hye Gwang [2 ]
Choi, Inpyo [6 ,7 ]
Kim, Tae-Don [6 ,7 ]
Hong, Kwan Soo [1 ,8 ]
Han, Eun Hee [1 ,6 ]
机构
[1] Korea Basic Sci Inst, Res Ctr Bioconvergence Anal, Cheongju 28119, South Korea
[2] Chungnam Natl Univ, Coll Pharm, Dept Toxicol, Daejeon 34134, South Korea
[3] Korea Basic Sci Inst, Res Ctr Mat Anal, Daejeon 34133, South Korea
[4] Tomocube Inc, Daejeon 34051, South Korea
[5] Korea Food Res Inst, Res Div Food Funct, Seongnam Si 55365, Jeonrabug Do, South Korea
[6] Korea Univ Sci & Technol UST, Daejeon 34113, South Korea
[7] Korea Res Inst Biosci & Biotechnol, Immunotherapy Res Ctr, Daejeon 34141, South Korea
[8] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, Daejeon 34134, South Korea
基金
新加坡国家研究基金会;
关键词
Biophysics; Cancer; Cell biology;
D O I
10.1016/j.isci.2022.105017
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The heterotypic CIC structures formed of cancer and immune cells have been observed in tumor tissues. We aimed to assess the feasibility of using heterotypic CICs as a functional biomarker to predict NK susceptibility and drug resistance. The heterotypic CIC-forming cancer cells showed a lower response to NK cyto-toxicity and higher proliferative ability than non-CIC cancer cells. After treatment with anticancer drugs, cancer cells that formed heterotypic CICs showed a higher resistance to anticancer drugs than non-CIC cancer cells. We also observed the formation of more CIC structures in cancer cells treated with anticancer drugs than in the non-treated group. Our results confirm the association between het-erotypic CIC structures and anticancer drug resistance in CICs formed from NK and cancer cells. These results suggest a mechanism underlying immune evasion in heterotypic CIC cancer cells and provide insights into the anticancer drug resis-tance of cancer cells.
引用
收藏
页数:21
相关论文
共 33 条
[1]   Emperipolesis of lymphocytes by mesothelial cells in pleural effusion involved by T-lymphoblastic lymphoma [J].
AbdullGaffar, Badr .
DIAGNOSTIC CYTOPATHOLOGY, 2020, 48 (12) :E22-E26
[2]   A three-dimensional hyaluronic acid-based niche enhances the therapeutic efficacy of human natural killer cell-based cancer immunotherapy [J].
Ahn, Young Ha ;
Ren, Long ;
Kim, Seok Min ;
Seo, Sang-Hwan ;
Jung, Cho-Rok ;
Kim, Da Seul ;
Noh, Ji-Yoon ;
Lee, Soo Yun ;
Lee, Hyunseung ;
Cho, Mi Young ;
Jung, Haiyoung ;
Yoon, Suk Ran ;
Kim, Jung-Eun ;
Lee, Sang Nam ;
Kim, Sohyun ;
Shin, Il Woo ;
Shin, Hong Sik ;
Hong, Kwan Soo ;
Lim, Yong Taik ;
Choi, Inpyo ;
Kim, Tae-Don .
BIOMATERIALS, 2020, 247
[3]   Cell-in-cell phenomenon associates with aggressive characteristics and cancer-related mortality in early oral tongue cancer [J].
Almangush, Alhadi ;
Maekitie, Antti A. ;
Hagstroem, Jaana ;
Haglund, Caj ;
Kowalski, Luiz Paulo ;
Nieminen, Pentti ;
Coletta, Ricardo D. ;
Salo, Tuula ;
Leivo, Ilmo .
BMC CANCER, 2020, 20 (01)
[4]  
Caruso R. A., 2012, Experimental Oncology, V34, P306
[5]   Prevalence of Heterotypic Tumor/Immune Cell-In-Cell Structure In Vitro and In Vivo Leading to Formation of Aneuploidy [J].
Chen, Yu-hui ;
Wang, Shan ;
He, Mei-fang ;
Wang, Yanyi ;
Zhao, Hua ;
Zhu, Han-yu ;
Yu, Xiao-min ;
Ma, Jian ;
Che, Xiao-juan ;
Wang, Ju-fang ;
Wang, Ying ;
Wang, Xiao-ning .
PLOS ONE, 2013, 8 (03)
[6]   Cell-in-cell phenomena in cancer [J].
Fais, Stefano ;
Overholtzer, Michael .
NATURE REVIEWS CANCER, 2018, 18 (12) :758-766
[7]   Focus on research: p53 - Master and commander [J].
Foulkes, William D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (25) :2539-2541
[8]   Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment [J].
Gao, Yanyun ;
Dorn, Patrick ;
Liu, Shengchen ;
Deng, Haibin ;
Hall, Sean R. R. ;
Peng, Ren-Wang ;
Schmid, Ralph A. ;
Marti, Thomas M. .
CANCER CELL INTERNATIONAL, 2019, 19 (01)
[9]   Phosphorylation of cyclin D1 at Thr 286 during S phase leads to its proteasomal degradation and allows efficient DNA synthesis [J].
Guo, Y ;
Yang, K ;
Harwalkar, J ;
Nye, JM ;
Mason, DR ;
Garrett, MD ;
Hitomi, M ;
Stacey, DW .
ONCOGENE, 2005, 24 (16) :2599-2612
[10]  
Hamann JC, 2019, METHODS MOL BIOL, V1880, P447, DOI 10.1007/978-1-4939-8873-0_28